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Abstract 
The link between neuropsychological impairments and chronic tobacco smoking is not 
clear and in the current literature there is a lack of robust analyses investigating this 
association. A systematic review of the literature was conducted in order to identify 
relevant longitudinal and cross-sectional studies conducted from 1946 to 2017. A 
meta-analysis was performed from 24 studies testing the performance of chronic 
tobacco smokers compared with non-smokers on neuropsychological tests related to 
eight different neuropsychological domains. The results revealed a cross-sectional 
association between neuropsychological impairments and chronic tobacco smoking in 
cognitive impulsivity, non-planning impulsivity, attention, intelligence, short term 
memory, long term memory, and cognitive flexibility, with the largest effect size being 
related to cognitive impulsivity (SDM=0.881, p <0.005), and the smallest effect size 
being related to intelligence (SDM=0.164, p<0.05) according to Cohen’s benchmark 
criteria. No association was found between chronic smoking and motor impulsivity 
(SDM=0.105, p=0.248).  Future research is needed to investigate further this 
association by focusing on better methodologies and alternative methods for nicotine 
administration. 
 
 
 
 
Keywords: Nicotine, chronic smoking, neuropsychology, impulsivity, memory, 
intelligence, attention, cognitive flexibility, meta-analysis. 
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1.Introduction 
Nicotine is a poisonous alkaloid and highly addictive psychoactive substance present 
in tobacco cigarettes (Benowitz,2009,2010; Mishra et al., 2015; Pontieri et al., 1996; 
Stolerman & Jarvis, 1995). Cigarettes are the primary form of tobacco consumed 
globally and are responsible for the death of approximately 6 million people each year 
worldwide (WHO, 2018). They contain over 4000 chemicals compounds, 43 of those 
are reported to be carcinogenic, including formaldehyde, cyanide, lead, carbon 
monoxide, acrolein, and arsenic (Rodgman & Perfetti, 2016; Talhout et al., 2011). The 
physical effects of chronic smoking are well known. In fact, there is a strong 
association between chronic tobacco smoking and physical diseases including 
cardiovascular diseases, respiratory diseases and various forms of cancer (Didkowska 
et al., 2016; Houghton et al., 2008; Ide et al., 2007; Margaritopoulos et al., 2016; 
McGrath et al., 2007; Mozaffarian et al., 2016). Direct and indirect exposure to nicotine 
have been also associated with neurobiological changes (Volkow et al. 2016; Yuan et 
al., 2015). Particularly, nicotine is reported to increment the number of acetylcholine 
receptors (nAChR) (Jasinska et al. 2014), which like other drugs, stimulate the release 
of dopamine in the ventral striatum (Brody et al., 2004; De Biasi & Dani 2011) and 
produce reinforcing effects that contribute to addiction (Rose, 2006). Nicotine use has 
been also associated with cognitive modulation, although the evidence for the 
influence of nicotine on cognition is complex. In fact, while nicotine consumed acutely 
has been reported to enhance cognition, particularly attention and memory (Heishman 
et al.2010; Potter & Newhouse, 2007), chronic nicotine use has been linked to 
cognitive impairments in midlife (Kalmijn 2002; Richards et al. 2003) and to cognitive 
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deterioration and various types of dementia in old age (Reitz et al., 2007; Sosa-Ortiz et 
al., 2012; Zhong et al., 2015). Researchers also investigated the co-occurring effects 
of nicotine use and different types of psychotropic drugs on the neuropsychological 
and neurobiological processes of individuals, proposing, for example, that nicotine 
may exacerbate neurological damages in alcohol dependent individuals (Durazzo et 
al., 2006), and that “opioid and nicotinic-cholinergic neurotransmitters systems interact 
in important ways to modulate nicotine and opioid effects” (Yoon et al., 2015, p.281).  
In contrast to the wealth of reviews and meta-analyses in the literature summarising 
the harmful effects of chronic smoking on individuals’ physical health (e.g. Gandini et 
al., 2008; Huxley & Woodward, 2011; Jayes et al., 2016; Sasco et al., 2004), the 
number of reviews investigating the neuropsychological effects of chronic nicotine and 
tobacco exposure is extremely scarce. In this sense, one of the most relevant 
examples is the systematic review conducted by Durazzo et al., (2010). According to 
their findings “chronic smoking is associated with deficiencies in auditory-verbal 
learning and/or memory, general intellectual abilities, visual search speeds, processing 
speed, cognitive flexibility, working memory and executive functions, across a wide 
age range”. (Durazzo et al., 2010, p.3776). More recently, a review conducted by 
Waisman Campos et al., (2016) highlighted the detrimental effects of nicotine on 
various neuropsychological domains. Memory, attention, and executive functioning 
were found to decline in middle aged adults classified as heavy smokers. 
Although the aforementioned reviews provide evidence about neuropsychological 
impairments as a result of chronic tobacco smoking, their findings should be 
considered cautiously. In fact, many of the studies included in these reviews didn’t 
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account statistically for confounding factors such as psychiatric disorders and 
comorbid alcohol and/or other substance abuse, as highlighted by the same authors.  
Currently, there is no clear link between chronic tobacco smoking and 
neuropsychological impairments and no evidence derived from meta-analyses. It is 
therefore essential to investigate quantitatively the association between chronic 
tobacco smoking and possible neuropsychological impairments. 
2. Literature search 
The “Preferred Reporting Items for Systematic Review and Meta Analysis” (PRISMA) 
guidelines (Liberati et al., 2009) and the “Meta Analysis for Observational Studies in 
Epidemiology” (MOOSE) guidelines (Stroup et al., 2000) were utilized to identify and 
assess relevant papers to include in this review. 
The inclusion criteria aimed to utilize any trial methodology, include chronic tobacco 
smokers aged 18 years or over, be published in English language literature and be 
categorized as case control, longitudinal, and/or cross-sectional studies. Longitudinal 
cohort studies were also included, however only the baseline data was used for this 
review so they were classified as cross-sectional studies. Additionally, the studies had 
to provide the name or a description of the neuropsychological tests utilised to assess 
the cognitive functions of individuals. This would have allowed them to be sorted in 
different neuropsychological domains (Baldacchino et al., 2012).  
The exclusion criteria used were the follows: 
(A) Cohorts including individuals under 18 years of age. 
(B) Cohorts including individuals with current illicit polydrug use and dependence. 
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(C) Cohorts including individuals diagnosed with any Axis-1 Psychiatric Illness (as 
defined by DSM IV/V). 
(D) Cohorts including individuals with alcohol dependence. 
(E) Cohorts including individuals with any history of serious head injury. 
(F) Cohorts including individuals who were HIV serotype positive. 
(G) Studies with no healthy non-smokers controls as comparator groups 
A computer based literature search was conducted in January 2017 to identify relevant 
papers for the current systematic review and meta-analysis. The following databases 
were used: Pubmed (1964 to 11th January 2017), Psychinfo (1980 to 17th January 
2017), Ovid Medline (1946 to 18th January 2017), Embase (1974 to 18th January 
2017), and Cochrane Central (1966 to 17th January 2017). The search term used were 
chronic OR long term AND nicotine OR tobacco OR smoking AND cognitive tests OR 
deficits OR impairments OR neuropsychological tests OR deficits OR impairments. 
Subsequently, the cognitive tests and neuropsychological tests search terms were 
removed and the names of specific cognitive tests were inserted, thus the databases 
searched again. Names of cognitive tests included ‘Wechsler Adult Intelligent Scale’, 
‘Two Back Test’, ‘Stroop Test’, ‘California Verbal Learning Test’, ‘Trail Making Test’, 
‘Ray Auditory Verbal Learning Test’, ‘Verbal Fluency’, ‘Wisconsin Card Sorting Test’, 
and ‘Gambling Test’. Lastly, the references of the selected papers were inspected and 
a snowballing technique was used to identify further relevant studies. 
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3. Analysis  
Meta-analytic techniques were employed to reach a quantitative estimate for the 
impact of chronic tobacco smoking on eight neuropsychological domains, including: 
Cognitive Impulsivity, Motor Impulsivity, Non-Planning impulsivity, Cognitive Flexibility, 
Attention, Intelligence, Short Term Memory, and Long-Term Memory. These domains 
were identified from the neuropsychological tests utilised by the studies included in the 
review following the guidelines of Baldacchino et al. (2012) (see Supplementary Table 
1). As the studies employed different neuropsychological tests to measure the impact 
of chronic tobacco smoking on the above domains, Standardized Mean Difference 
(SDM) effect sizes were used. A random effect model was preferred over a fixed effect 
model as the studies included in the review were not functionally equivalent and the 
assumption that the true effect size was the same in all studies was not met 
(Borenstein et al., 2007). Heterogeneity between the studies included in the meta-
analysis was assessed by Cochran’s Q and I2 tests (Higgins et al., 2003; Cochran, 
1950). 
The effect sizes for the individual studies and the respective summary effect sizes for 
each neuropsychological domain were computed through the Comprehensive Meta-
Analysis Version III software (CMA, 2017). A large effect size would have been 
determined by a value of 0.8, a medium effect size would have been determined by a 
value of 0.5, and a small effect size would have been determined by a value of 0.2 
(Cohen, 1988). The criterion for statistical significance was considered to be p<0.05 
(Cohen, 1994). 
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A meta-regression was conducted to identify significant relationships between each of 
the continuous moderator variables (chronicity of nicotine smoking, age and 
educational status) and the effect size. The meta-regression was only performed in the 
neuropsychological domains in which eight or more studies were available (Thompson 
& Higgins, 2002). 
 
3.1 Publication Bias 
In scientific literature there is the tendency to publish more frequently studies with 
statistically significant results than studies deemed to be statistically insignificant and 
with low effect sizes (Dickersin, 2005; Hedges, 1989). Thus, there is a possibility that 
studies included in a meta-analysis would be biased and consequently reflected in the 
results of the quantitative synthesis. In order to assess the possible presence of such 
bias a visual inspection of funnel plots was carried out alongside the statistical 
computation of Fail Safe N (Orwin, 1983). Fail Safe N refers to the number of missing 
studies that would allow to determine how many of these studies would bring the 
overall effect of the current meta-analysis to a specified level other than zero and that 
would be needed to change the result from significant to non-significant (Orwin, 1983; 
Rosenthal, 1979). 
 
3.2 Assessment of study quality  
The National Institute of Health (NIH) cross-sectional and case-control quality 
assessment tools were utilized to evaluate the quality of the papers included in the 
review. Studies were classed as ‘poor’, ‘fair’, or ‘good’ (“Study Quality Assessment 
Tools.,2017”). The quality of the papers was assessed by three reviewers (AB, ST, 
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and AAC) in order to reduce bias. Of the 24 studies included in the meta-analysis, 11 
studies were classified as ‘Fair’, 9 studies were classified as ‘Good’, and 4 studies as 
‘Poor’. These studies were categorized as ‘poor’ (Deary et al., 2003; Hatta et al., 2006; 
Hill, 1989; Launer et al., 1996) because they didn’t account statistically for several 
confounding factors such as age, gender, and years of education.  
The four studies that were classified as ‘poor’ were included in the quantitative 
synthesis to avoid reducing the sample size and consequently decreasing the 
statistical power of the meta-analysis (Hedges, & Pigott, 2001) as no relevant data 
were missing and they didn’t present serious methodological flaws. A sensitivity 
analysis conducted a posteriori revealed the absence of bias to the results which 
justified their inclusion. 
 
4. Results 
In total, 2611 papers were identified through the search conducted on relevant 
databases in combination with other sources. Papers were screened for relevance and 
1837 studies excluded. Subsequently, studies were assessed for eligibility through title 
and abstract inspection and duplicates were removed, eliminating 717 papers. The 
remaining 62 papers were screened for eligibility utilizing the inclusion and exclusion 
criteria. Finally, 15 case-control studies and 9 cross-sectional studies were included in 
the quantitative synthesis (Fig.1; QUOROM).
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Figure 1. Neuropsychological associations with Chronic Nicotine Use: Quality of Reporting Of Meta-
analysis (QUOROM): 1946-2017 
 
Records identified through 
database searching 
(n =2190) 
Additional records identified 
through other sources 
(n =421  ) 
After irrelevant papers were removed 
(n =1837) 
Title and abstract screened 
(n =779) 
Full papers assessed for 
eligibility 
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No data for smoking only (n=5) 
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No raw data available 
(n =12 ) 
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(n =717) 
Duplicates (n=254) 
Non human subjects (n= 178) 
Cohort with other psychiatric 
illness (n=119) 
No neuropsychological assessment 
(n=65) 
No specific neurpsychological 
assessment (n=1) 
No control (n=11) 
Cohort under 18 years (n=54) 
Control with uncontrolled polydrug 
use (n=10) 
Cohort including brain injury (n=6) 
Cohort including HIV+ individuals 
(n=4) 
Abstract only (n=6) 
Literature review (n=8) 
No english version available (n= 1) 
 
Studies included in the 
quantitative synthesis 
(Meta Analysis) 
(n =24) 
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Several studies included in the quantitative synthesis reported data from different 
comparator groups (e.g. ‘quitters’, ’light smokers’, and ‘occasional smokers’). Thus, in 
accordance with the aim of the study and with the inclusion and exclusion criteria only 
the appropriate comparator groups were included in the meta-analysis. These are 
presented in Table 1 below alongside the excluded comparator groups. 
Table 1. Comparator groups included and excluded in the meta-analysis 
 
 
N 
Included comparator groups  
Chronic/heavy smokers   24 
Never/Non-smokers  24 
Excluded comparator groups  
Light smokers 
 
1 
Medium/moderate smokers 
 
2 
Ex-smokers (recent and long-term) 
 
10 
Occasional/non-dependent smokers 
 
3 
Never smoked-current alcohol drinkers 
 
1 
Ex-smokers-ex alcohol drinkers 
 
1 
Ex-smokers-current alcohol drinkers 
 
1 
Current smokers-ex alcohol drinkers 
 
1 
Current smokers-current alcohol drinkers 
 
1 
Dependent to Marijuana 
 
1 
Long-term abstinent alcohol dependents -
smokers 
 
1 
Long-term abstinent alcohol dependents-non 
smokers 
 
1 
Note. Out of the 24 studies included in the meta-analysis only six studies compared chronic nicotine smokers with 
non-smokers without using other comparator groups. The majority of the studies used more than one comparator 
but these groups were excluded from the meta-analysis.  
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Demographic data were extracted from a total of 3756 chronic nicotine smokers and 
7669 non-smokers healthy controls. The mean age range of individuals varied from 
21.5 years (Chamberlain et al., 2012) to 76.8 years old (Galanis et al., 1997). Several 
studies compared individuals within particular age groups, such as young adults 
(Chamberlain et al., 2012; Deary et al., 2003; Paelecke-Habermann et al., 2013; 
Smolka et al. 2004; Yakir et al., 2006) middle aged adults (Carim-Todd et al., 2015; 
Durazzo et al., 2012; Friend et al., 2005; Hatta et al., 2006; Kalmijn et al., 2002;Luhar 
et al., 2013; Sabia et al., 2012, Schinka et al., 2002), and elderly (Chen et al., 2003; 
Galanis et al., 1997; Hill et al., 1989; Launer et al., 1996; Razani et al., 2004). Average 
years of education varied from 2.9 years (Chen et al., 2003) to 16 years (Carim-Todd 
et al., 2015). Information about smoking pack years was extracted from just 8 studies. 
The lowest average pack years were 4.26 (Luhar et al.,2013), while the highest were 
73.73 (Razani et al.,2004). The studies were conducted in 11 different countries, 
particularly: USA, Israel, Egypt, Netherlands, UK, Taiwan, Japan, Sweden, China, 
Germany, and Australia. The demographic data and the quality assessment for each 
study are presented in Table 2 below.
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Table 2. Demographic data 
Paper Quality Country Type of 
study 
        Chronic Nicotine smokers group Non-smokers control group 
    n Age 
Mean 
(SD)in 
years 
Gende
r 
Years of 
education 
Mean (SD) 
or % 
Pack 
years 
n Age Mean 
(SD) in 
years 
Gende
r 
Years of 
education 
Mean (SD) 
or % 
Pack 
years 
Carim-Todd et 
al. (2016) 
Fair USA Case-
control 
23 34.75 
(1.667) 
9M 
14F 
18.2%>16 
years 
n.a. 25 33.68 
(1.61) 
11M 
4F 
40%>16 
years 
n.a. 
Chamberlain et 
al. (2012) 
Fair UK and 
USA 
Case-
control 
37 21.5 
(3.58) 
28M 
9F 
86.8% 
College or 
above 
n.a. 177 21.11 
(3.13) 
128M 
49F 
91.6% 
College or 
above 
n.a. 
Chen et al. 
(2003) 
Good Taiwan Cross-
sectional 
195 72.5 
(6.3) 
195M 2.9 
(3.4) 
n.a. 68 72.3 
(6.2) 
68M 4.4 (3.8) n.a. 
Deary et al. 
(2003) 
Poor UK Cross-
sectional 
34 80 n.a. n.a. n.a. 205 80 n.a. n.a. n.a. 
Durazzo et al. 
(2012) 
Good USA Case-
control 
27 48.9 
(8.4) 
23M 
4F 
14.4 
(1.6) 
29.8 
(14.0) 
30 44.4 
(8.7) 
26M 
4F 
15.7 
(2.0) 
0 
Elwan et al. 
(1996) 
Fair Egypt Case-
control 
60 n.a. 60M n.a. n.a. 114 n.a. 69M 
45F 
n.a. n.a. 
Ernst et al. 
(2001) 
Fair USA Case-
control 
14 n.a. 6M 
8F 
n.a. 18.54 9 n.a. 3M 
6F 
n.a. 0 
Friend et al. 
(2005) 
Fair USA Case-
control 
84 n.a. n.a. n.a. n.a. 74 n.a. n.a. n.a. n.a. 
Galanis et 
al.(1997) 
Good USA Cross-
sectional 
921 76.8 
(4.2) 
921M 12% 
College or 
above 
n.a. 1174 78.4 
(4.8) 
1174M 21% 
College or 
above 
n.a. 
Hatta et al. 
(2006) 
Poor Japan Cross-
sectional 
130 62.27 
(9.75) 
n.a. 7.66 
(2.41) 
n.a. 295 63.1 
(9.2) 
n.a. 10.4 
(2.3) 
n.a. 
Hill et al. (1989) Poor USA Case-
control 
11 73.7 
(5.5) 
3M 
8F 
13.0 
(3.0) 
n.a. 53 71.0 
(4.6) 
14M 
39F 
13.4 
(3.4) 
n.a. 
Hill et al. (2003) Good Sweden Case- 
control 
164 n.a. n.a. n.a. n.a. 438 n.a. n.a. n.a. n.a. 
Kalmijn et al. 
(2002) 
Good Netherlands Cross-
sectional 
530 n.a. 268M 
261F 
n.a. 22.3 
(13.5) 
618 n.a. 205M 
413F 
n.a. 0 
14 
 
   
 
Launer et 
al.(1996) 
Poor Netherlands Cross-
sectional 
110 74.1 
(4.0) 
110M 88.6%>6 
years 
42.87 91 75.7 
(5.1) 
91M 84.6>6 years 0 
Luhar et al. 
(2013) 
Fair USA Case-
control 
6 47.0 
(7.8) 
4M 
2F 
14.3 
(3.3) 
4.26 
(3.25) 
7 50.4 
(9.8) 
4M 
3F 
14.3 
(2.1) 
0 
Lyvers et al. 
(2013) 
Fair China and 
Australia 
Case- 
control 
215 n.a. n.a. n.a. n.a. 104 n.a. n.a. n.a. n.a. 
Lyvers et al. 
(2014) 
Fair Australia Case- 
control 
61 n.a. n.a. n.a. n.a. 86 n.a. n.a. n.a. n.a. 
Paelecke-
Habermann et 
al. (2013) 
Good Germany Case-
control 
27 25.85 
(7.99) 
7M 
20F 
n.a. 7.54 25 24.84 
(7.47) 
7M 
18F 
n.a. 0 
Paul et al. 
(2006) 
Good Australia Case-
control 
62 36.42 
(13.25) 
28M 
34F 
13.94 
(2.09) 
n.a. 62 35.52 
(15.51) 
32M 
30F 
14,58 
(2.35) 
n.a. 
Razani et al. 
(2004) 
Fair USA Case-
control 
13 63.62 
(9.23) 
4M 
9F 
13.28 
(2.29) 
73.73 
(26.48) 
66 69.06 
(7.88) 
9M 
57F 
14.96 
(2.05) 
2.00 
(2.53) 
Sabia et al. 
(2012) 
Fair UK Cross-
sectional 
730 55.22 468M 
262F 
n.a. n.a. 3575 55.66 2398M 
1177F 
n.a. n.a. 
Schinka et al. 
(2001) 
Good USA Cross-
sectional 
174 38.41 
(2.49) 
174M 12.88 
(2.26) 
20.29 
(11.97) 
204 38.36 
2.25 
204M 12.76 
(2.25) 
0 
Smolka et al. 
(2004) 
Fair Germany Case-
control 
37 24.9 
(3.2) 
37M n.a. 9.04 18 27.1 
(4.3) 
18M n.a. 0 
Yakir et al. 
(2006) 
Good Israel Case-
control 
91 24.2 
(2.1) 
91F 13.4 
(1.4) 
n.a. 151 23.1 
(2.1) 
151F 13.7 
(1.7) 
n.a. 
Note.  Several studies presented demographic data without providing the Mean and Standard Deviation (SD). These data are described in the above table as they were reported in 
the respective studies. N= total number in study;  M= Males; F= Females; n.a.= not applicable; Pack Years= a person's cigarette consumption calculated as the packs of cigarettes 
smoked per day, multiplied by the length of consumption in years. 
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4.1 Neuropsychological domains 
Quantitative data extracted from the selected studies revealed the possibility to 
conduct 62 effect size measurements. These are illustrated in Figures 2-9 below. 
Fail Safe N results revealed the absence of publication bias for the inclusion of 
studies testing cognitive impulsivity, non-planning impulsivity, cognitive flexibility, 
attention, intelligence, short and long-term memory, as a reasonable number of 
studies would be required to change the effect sizes from significant to non-
significant, with the exception for motor impulsivity  (p<0.05). Fail Safe N tests 
results are related effect sizes are listed in Table 3 below. 
Table 3. Fail Safe N Tests Results 
Cognitive 
Domains 
N p Fail safe N 
Cognitive 
impulsivity 
6 0.003** 101 
Motor 
impulsivity  
4 0.248 0.00 
Non planning 
impulsivity 
8 0.000** 127 
Cognitive 
flexibility  
9 0.022* 161 
Attention 11 0.003** 26 
Intelligence 6 0.015* 34 
Short term 
memory 
11 0.001** 100 
Long term 
memory 
6 0.002** 51 
Note. P= Significance,* significant at the p<0.05 level, ** significant at the p<0.01 level.  
N= Total number of studies 
 
 
For Cognitive Impulsivity a significant and large effect size of 0.881 was found in 
favour of the non-smokers control group (z=2.998, p<0.005) revealing the tendency 
for chronic tobacco smokers to opt for small immediate rewards over larger delayed 
rewards in contrast to non-smokers. Results of Q and I2 tests Indicated 
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heterogeneity between the six pooled studies (Q=114.12,p=0.00, I2=95.62). Details 
are depicted in Figure 2 below. 
 
 
 
 
 
 
 
 
 
 
 
For Motor Impulsivity a non-significant effect size of 0.105 was found in favour of 
the non-smokers control group (z=1.156, p=0.248). Results of Q and I2 tests 
Indicated homogeneity between the four pooled studies (Q=1.151,p=0.68, I2=0.00) . 
Details are illustrated in Figure 3 below. 
 
 
 
 
 
 
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standard  Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Carim-Todd et al. 2016 DDT 5.164 0.498 0.248 4.189 6.140 10.376 0.000 
Chamberlain et al.2012 CGT  0.130 0.181 0.033 -0.225 0.484 0.718 0.473 
Hatta et al. 2006 D-CAT 0.033 0.094 0.009 -0.151 0.218 0.354 0.723 
Lyvers et al. 2013 FRSBE 0.346 0.120 0.014 0.110 0.581 2.876 0.004 
Lyvers et al. 2014 FRSBE 0.811 0.174 0.030 0.470 1.152 4.662 0.000 
Yakier et al. 2006 MFFT 0.170 0.133 0.018 -0.090 0.431 1.281 0.200 
0.881 0.294 0.086 0.305 1.458 2.998 0.003 
-4.00 -2.00 0.00 2.00 4.00 
Favours chronic smokers Favours non-smokers 
Cognitive Impulsivity: Chronic tobacco smokers vs  non-smokers 
 
Figure 2. Cognitive Impulsivity Forest Plot. (std diff= standard difference; Z value= one sample Z statistic; p 
value=probability that Z statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for 
the effect size; upper limit= upper limit of the 95% confidence interval for the effect size; DDT= Delay Discounting Test; 
CGT= Cambridge Gambling Task; D-CAT= Digit Cancellation Test; FRSBE=Frontal Systems Behavior Scale; 
MFFT=Matching Familiar Figures Test) 
  
  
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standard  Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Chamberlain et al. 2012 SST 0.255 0.181 0.033 -0.100 0.610 1.407 0.160 
Yakir et al.2006 Stroop 0.009 0.133 0.018 -0.251 0.269 0.070 0.944 
Schinka et al.2002 Stroop  0.197 0.212 
0.045 -0.219 0.613 0.927 0.354 
Razani et al.2004 Stroop 0.001 0.303 
0.092 -0.593 0.596 0.005 0.996 
0.105 0.091 0.008 -0.073 0.284 1.156 0.248 
-4.00 -2.00 0.00 2.00 4.00 
Favours  chronic smokers Favours non-smokers 
Motor Impulsivity: Chronic tobacco smokers vs  non-smokers 
Figure 3. Motor Impulsivity Forest Plot.( std diff:=standard difference; Z value:=one sample Z statistic; p value= probability 
that Z statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for the effect size; 
upper limit= upper limit of the 95% confidence interval for the effect size; SST= Stop Signal Task; Stroop= Stroop Task) 
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For Non Planning Impulsivity a significant and medium effect size of 0.505 was 
found in favour of the non-smokers control group (z=3.615,p<0.001), showing a 
lesser capacity for chronic tobacco smokers to solve problems by thinking ahead 
and by searching for an appropriate solution in contrast to non-smokers. Results of 
Q and I2 tests Indicated heterogeneity between the eight pooled studies ( 
Q=49.564,p=0.00, I2=85.88). Details are depicted in Figure 4 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standard  Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Chamberlain et al. 2012 SOC 0.566 0.183 0.033 0.207 0.924 3.094 0.002 
Ernst et al.2001 logical Reasoning 0.175 0.428 0.183 -0.664 1.014 0.408 0.683 
Hill et al.1989 WAIS-R 0.681 0.337 0.113 0.021 1.341 2.022 0.043 
Hill et al.2003 WAIS-R 0.029 0.092 0.008 -0.151 0.208 0.315 0.753 
Lyvers et al.2014 FRSBE 0.745 0.173 0.030 0.406 1.083 4.305 0.000 
Razani et al.2004 ROCFT 2.161 0.349 0.122 1.477 2.845 6.196 0.000 
Sabia et al.2012 AH4IT 0.214 0.041 0.002 0.134 0.294 5.263 0.000 
Yakir et al.2006 TOL 0.188 0.172 0.030 -0.149 0.525 1.092 0.275 
0.505 0.140 0.020 0.231 0.780 3.615 0.000 
-4.00 -2.00 0.00 2.00 4.00 
Favours chronic smokers Favours non-smokers 
Non Planning Impulsivity: Chronic tobacco smokers vs non-smokers 
 
Figure 4. Non Planning Impulsivity Forest Plot. (std diff= standard difference; Z value= one sample Z statistic; p value: 
probability that Z statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for the effect 
size; upper limit= upper limit of the 95% confidence interval for the effect size; SOC= Stockings of Cambridge Test; Logical 
Reasoning=Logical Reasoning Tests; WAIS-R=Wechsler Adult Intelligence Scale Test; FRSBE=Frontal Systems Behavior 
Scale; ROCFT= Rey–Osterreith Complex Figure Test;AH4IT= Alice Heim 4 Test, TOL=Tower of London Test) 
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For Cognitive Flexibility a significant effect size of 0.450 was found in favour of the 
non-smokers control group (z=2.265, p<0.05), indicating an impaired capacity for 
chronic tobacco smokers to generate appropriate behavioral responses while 
switching between cognitive processes in contrast to non-smokers. Results of Q 
and I2 tests Indicated heterogeneity between the nine pooled studies (Q=112.10, 
p=0.00, I2=92.86). Details are depicted in Figure 5 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standard  Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Elwan et al.1997 TMT-B 0.065 0.320 0.102 -0.563 0.692 0.202 0.840 
Hill et al.1989 Word Fluency 0.394 0.333 0.111 -0.259 1.047 1.184 0.237 
Lyvers et al.2013 FRSBE  1.504 0.133 0.018 1.242 1.765 11.267 0.000 
Lyvers et al. 2014 FRSBE 0.745 0.173 0.030 0.406 1.083 4.305 0.000 
Friend et al.2005 TMT-B(Time) 0.563 0.163 0.026 0.245 0.882 3.465 0.001 
Razani et al.2004 WCST(Errors) 0.491 0.306 0.094 -0.109 1.091 1.605 0.109 
Sabia et al.2012 Word Fluency 0.133 0.041 0.002 0.053 0.213 3.275 0.001 
Smolka et al.2004 Word Fluency 0.000 0.287 0.083 -0.563 0.563 0.000 1.000 
Paul et al.2006 TMT-B 0.003 0.180 0.032 -0.349 0.355 0.019 0.985 
0.450 0.199 0.039 0.060 0.839 2.265 0.024 
-4.00 -2.00 0.00 2.00 4.00 
Favours chronic smokers Favours non-smokers 
Cognitive Flexibility: Chronic tobacco smokers vs non-smokers 
 
Figure 5. Cognitive Flexibility Forest Plot. (std diff= standard difference; Z value= one sample Z statistic; p value: probability 
that Z statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for the effect size; upper 
limit= upper limit of the 95% confidence interval for the effect size; TMT-B: Trail Making Test; Word Fluency=Word Fluency 
Task; FRSBE=Frontal Systems Behavior Scale; WCST=Wisconsin Card Sorting Test) 
  
  
19 
 
   
 
For Attention a significant and small effect size of 0.196 was detected in favour of 
the non-smokers control group (z=2.944, p<0.005), showing a slightly better 
capacity for non-smokers to attend relevant inputs while rejecting irrelevant 
information and to detect unpredictable signals during prolonged periods of 
concentration in contrast to chronic tobacco smokers. Results of Q and I2 tests 
Indicated heterogeneity between the 11 pooled studies ( Q=14.66,p=0.15,I2=31.76). 
Details are depicted in Figure 6 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
          
 
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standard  Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Chamberlain et al.2012 RVIP  0.579 0.183 0.033 0.220 0.937 3.164 0.002 
Ernst et al. 2001 TLST 0.060 0.427 0.183 -0.778 0.898 0.140 0.888 
Hill et al.1989 TMT-A 0.318 0.333 0.111 -0.334 0.970 0.957 0.339 
Paelecke et al.2013 ICST 0.239 0.279 0.078 -0.307 0.785 0.858 0.391 
Paul et al.2006 RTT 0.224 0.180 0.032 -0.129 0.578 1.245 0.213 
Razani et al.2004 WAIS 0.035 0.303 0.092 -0.559 0.630 0.117 0.907 
Smolka et al.2004 WAIS 0.099 0.288 0.083 -0.464 0.663 0.346 0.730 
Friend et al.2005 TMT-A 0.444 0.156 0.024 0.138 0.750 2.844 0.004 
Yakir etal.2006 CPT 0.123 0.139 0.019 -0.148 0.395 0.890 0.373 
Elwan et al.1997 TMT-A 0.131 0.217 0.047 -0.294 0.556 0.603 0.547 
Galanis et al.1997 CASI 0.037 0.044 0.002 -0.049 0.124 0.847 0.397 
0.196 0.066 0.004 0.065 0.326 2.944 0.003 
-4.00 -2.00 0.00 2.00 4.00 
Favours chronic smokers Favours non-smokers 
Attention: Chronic tobacco smokers vs non-smokers 
 
 
Figure 6. Attention Forest Plot. (std diff= standard difference; Z value= one sample Z statistic; p value: probability that Z 
statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for the effect size; upper 
limit= upper limit of the 95% confidence interval for the effect size; RVIP=Rapid Visual Information Processing Task; TLST= 
Two Letter Search Task; TMT-A=Trail Making Test; ICST=Ice Cream Seller Task; RTT=Reaction Time Test; 
WAIS=Wechsler Adult Intelligence Scale; CPT=Cognitive Performance Test; CASI=Cognitive Abilities Screening Test) 
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For Intelligence a significant and small effect size of 0.164 was found in favour of 
the control group (z=2.423, p<0.05), indicating the tendency for chronic tobacco 
smokers to perform worse than non-smokers in several domains related to the 
overall intelligence and cognitive capacity of individuals such as verbal reasoning, 
verbal comprehension, and perceptual organization. Results of Q and I2 tests 
indicated heterogeneity between the six pooled studies (Q=26.23,p=0.00, I2=80.93). 
Details are depicted in Figure 7 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
For Short Term Memory a significant effect size of 0.413 was found in favour of the 
non-smokers control group (z=3.537, p<0.001), showing a better capacity for non-
smokers to recall information presented shortly before in comparison to chronic 
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standard  Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Chen et al.2003 CASI 0.124 0.141 0.020 -0.153 0.400 0.878 0.380 
Deary et al.2003 MHT 0.435 0.186 0.035 0.070 0.800 2.334 0.020 
Durazzo et al.2012 WAIS III 0.754 0.313 0.098 0.139 1.368 2.405 0.016 
Launer et al.1996 MMSE 0.172 0.142 0.020 -0.106 0.451 1.214 0.225 
Sabia et al.2012 MHV 0.090 0.041 0.002 0.010 0.170 2.214 0.027 
Friend et al.2005 SILS 0.030 0.159 0.025 -0.282 0.343 0.189 0.850 
0.164 0.068 0.005 0.031 0.297 2.423 0.015 
-4.00 -2.00 0.00 2.00 4.00 
Favours chronic smokers Favours non-smokers 
Intelligence: Chronic tobacco smokers vs non-smokers 
 
Figure 7. Intelligence Forest Plot. (std diff:=standard difference; Z value:=one sample Z statistic; p value: probability 
that Z statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for the effect size; 
upper limit= upper limit of the 95% confidence interval for the effect size; CASI=Cognitive Abilities Screening Test; 
Moray House Test; WAIS=Wechsler Adult Intelligence Scale; MMSE= Mini Mental State Examination; MHV= Mill Hill 
Vocabulary Test; SILS= Shipley Institute of Living Scale) 
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tobacco smokers. Results of Q and I2 tests indicated heterogeneity between the 11 
pooled studies (Q=33.44,p=0.00 I2=70.10) . Details are depicted in Figure 8 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For Long Term Memory a significant effect size of 0.621 was detected in favour of 
the non-smokers control group (z=3.539, p<0.001), indicating a better capacity for 
non-smokers to retain information over longer periods of time in contrast to chronic 
tobacco smokers. Results of Q and I2 tests indicated heterogeneity between the six 
pooled studies (Q=16.49,p=0.006 I2=69.68). Details are depicted in Figure 9 below. 
 
 
 
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standar
d  
Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Chamberlain et al.2012 SWM 0.417 0.182 0.033 0.060 0.773 2.290 0.022 
Durazzo et al.2012 BVMT 0.759 0.275 0.075 0.221 1.297 2.763 0.006 
Ernst et al.2001 2BT 1.337 0.471 0.221 0.415 2.260 2.842 0.004 
Hill et al.1989 WMSR 0.118 0.331 0.110 -0.531 0.768 0.357 0.721 
Luhar et al.2013 WAIS 0.672 0.572 0.327 -0.449 1.792 1.175 0.240 
Paelecke et al.2013 WMSR 0.234 0.279 0.078 -0.312 0.780 0.840 0.401 
Razani et al.2004 LMT 0.139 0.304 0.092 -0.456 0.735 0.459 0.646 
Sabia et al.2012 VM 0.160 0.041 0.002 0.080 0.240 3.936 0.000 
Yakir et al.2006 WM  0.230 0.133 0.018 -0.031 0.491 1.728 0.084 
Schinka et al.2002 HVLT 0.000 0.212 0.045 -0.416 0.416 0.000 1.000 
Elwan et al.1997 PASAT 1.174 0.197 0.039 0.787 1.561 5.950 0.000 
0.413 0.117 0.014 0.184 0.641 3.537 0.000 
-4.00 -2.00 0.00 2.00 4.00 
Favours chronic smokers Favours non-smokers 
Short-Term Memory: Chronic tobacco smokers vs non-smokers 
Figure 8. Short Term Memory Forest Plot. (std diff= standard difference; Z value:=one sample Z statistic; p value:=probability 
that Z statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for the effect size; upper 
limit= upper limit of the 95% confidence interval for the effect size; SWM= Spatial Working Memory Task; BVMT= Brief 
Visuospatial Memory Test; 2BT= Two Back Test; WMSR= Wechsler Memory Scale; WAIS= Wechsler Adult Intelligence 
Scale; LMT= Letter Memory Test; VM= Verbal Memory Test; WM= Working Memory Test; HVLT= Hopkins Verbal Learning 
Test; PASAT= Paced Auditory Serial Addition Test) 
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4.2 Subgroup analysis: Meta-regression 
There were not enough studies to have the power to test an association between 
chronicity of tobacco smoking and educational status as the moderator variables 
and all the neuropsychological domains. We were limited in reporting the Z value 
and associated p values in Attention and Short-Term Memory for age. It identified a 
significant effect in Attention (slope Z= -2.27, p=0.02) and a non-significant effect in 
Short Term Memory (slope Z= -1.31, p=0.19) (Figures 10a and 10b) with older 
chronic tobacco smokers exhibiting greater neuropsychological impairment when 
compared with younger peers. 
 
Study name Outcome Statistics for each study Std diff in means and 95% CI 
Std diff  Standar
d  
Lower  Upper  
in means error Variance limit limit Z-Value p-Value 
Yakir et al.2006 Verbal Recall  0.014 0.133 0.018 -0.246 0.274 0.107 0.915 
Kalmijin et al.2002 AVLT 0.300 0.060 0.004 0.183 0.417 5.039 0.000 
Durazzo et al.2012 CVLT 1.008 0.282 0.079 0.456 1.559 3.579 0.000 
Hill et al.1989 WMSR 0.524 0.335 0.112 -0.131 1.180 1.567 0.117 
Luhar et al.2013 WMS 0.694 0.573 0.328 -0.429 1.816 1.211 0.226 
Elwan et al.1997 PASAT 1.174 0.197 0.039 0.787 1.561 5.950 0.000 
Paelecke et al.2013 WMS 0.930 0.292 0.085 0.357 1.502 3.182 0.001 
0.621 0.175 0.031 0.277 0.964 3.539 0.000 
-4.00 -2.00 0.00 2.00 4.00 
Favours chronic smokers Favours non-smokers 
Long-Term Memory: Chronic tobacco smokers vs non-smokers 
 
Figure 9. Long Term Memory Forest Plot. (std diff= standard difference; Z value= one sample Z statistic; p value= 
probability that Z statistics is significantly different than 0; lower limit= lower limit of the 95% confidence interval for the 
effect size; upper limit= upper limit of the 95% confidence interval for the effect size; Verbal Recall= Verbal Recall Test; 
AVLT= Auditory Verbal Learning Test; CVLT= California Verbal Learning Test; WMSR= Wechsler Memory Scale Revised; 
WMS= Wechsler Memory Scale; PASAT= Paced Auditory Serial Addition Test) 
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Figure 10 a. Meta-regression of chronic nicotine users by age with respect to Attention 
 
 
Figure 10 b. Meta-regression of chronic nicotine users by age with respect to Short Term Memory 
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5.Discussion 
5.1 Key findings 
We conducted a meta-analysis with the aim to provide a quantitative synthesis for 
the associations between chronic tobacco smoking and neuropsychological 
functions of individuals across a wide age range. The results underlined a cross-
sectional association between chronic tobacco smoking and cognitive impairments 
in seven neuropsychological domains such as cognitive impulsivity, non-planning 
impulsivity, cognitive flexibility, attention, intelligence, short term memory, and long-
term memory. This supports the findings of Durazzo et al., (2010). The above 
results illustrated that the most robust impairments are related to the cognitive 
impulsivity domain while the least robust impairments are related to the attention 
and intelligence domains. Fail Safe N results are sufficiently high to exclude 
possible publication bias (see Table 6).  
These results are in line with the review conducted by Waisman Campos et al. 
(2016) that illustrated a decline in cognitive areas such as attention, memory and 
Executive functioning in middle aged adults considered to be heavy tobacco 
smokers, and with reviews that indicated a significant cognitive decline in elderly 
exposed chronically to tobacco (Almeida et al.,2002; Anstey et al., 2007; Ott et al., 
2004; Peters et.al, 2008), suggesting that chronic smokers may be at major risk for 
dementia compared to non-smokers. The largest effect size (SMD=0.881) was 
found in favor for the cognitive impulsivity domain. This result support previous 
research (Bloom et al., 2013; Mitchell, 2004; Sweitzer et al., 2008) that illustrated 
how chronic nicotine consumption is strongly related to an increase in impulsivity 
and to a devaluation of future larger rewards over most immediate and smaller 
25 
 
   
 
rewards in temporal discounting tasks. No cross-sectional association was found 
between motor impulsivity and chronic smoking, contrasting the findings of a recent 
review conducted by Kale et al. (2018) to assess the magnitude of the relationship 
between different dimensions of impulsivity and tobacco smoking. A possible 
explanation for the current findings could be related to the small number of studies 
included in the meta-analysis assessing the link between motor impulsivity and 
chronic smoking (n=4). Thus, indicating the possible presence of bias towards a 
non-statistically significant association (Higgins & Thompson, 2002). 
 
5.2. Strengths and Limitations  
A search technique comprising online databases and scientific journals was 
employed to identify studies to include in the quantitative synthesis. Generic terms 
were subsequently substituted with names of neuropsychological tests. The 
inclusion and exclusion criteria were rigorous, thus aiding the exclusion of 
confounding factors such as psychiatric illness and polydrug use. Other possibly 
confounding factors that could have impacted the results of the studies included in 
the review encompassed demographic variables such as gender, age, educational 
level, socioeconomic status, and co-occurring consumption of alcohol and other 
drugs. Previous research demonstrated that these variables could affect negatively 
the cognitive ability of individuals (Mani et al., 2013; Murman, 2015; Piumatti, 
2018;Salthouse 2009 ). Confounding factors were accounted for in the majority of 
the studies included in the meta-analysis, although several studies controlled 
statistically for just one or few variables and/or differed in relation  to which 
confounders were reported  (Chen et al., 2002; Friend et al., 2005; Galanis et al., 
26 
 
   
 
1997; Hatta et al., 2006; Launer et al., 1996; Paelecke-Habermann et al., 2013; 
Paul et al., 2006; Schinka et al., 2001). Because of this, it wasn’t possible to include 
confounding factors as moderators in the quantitative synthesis. This might be 
considered a limitation of our study.  
The number of pack years varied consistently (from 4.26 to 73.73). This could be 
also considered a confounding factor as several studies included in the review 
revealed a negative link between the number of pack years and cognitive 
performance. Specifically, the cognitive performance of participants decreased as 
the number of pack years increased. Considering that just eight studies included in 
the current review reported the number of participants’ pack years, it was not 
possible to assess whether unreported pack years from the other 15 studies would 
have influenced the outcomes of the current quantitative synthesis.  
Methodological problems may also be related to the only inclusion of Non-
Randomized Studies (NRS) such as case-control and cross-sectional studies in the 
review, as the non-random allocation of participants to groups could imply a large 
and unpredictable bias leading to over-estimations or under-estimations of 
treatment effects (Deeks et al., 2003). The inclusion of NRS in the review is due to 
the lack of Randomized Controlled Trials (RCTs) in the literature.  
Another drawback of the current study may be related to the absence of longitudinal 
data in the meta-analysis as a consequence of avoiding bias related to earlier 
deaths of smokers compared to non-smokers. In fact, longitudinal data could be 
useful in determining developmental changes related to chronic smoking and 
neuropsychological impairments as age may influence significantly the cognitive 
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functions of individuals (Murman, 2015;Tucker-Drob, 2011). Furthermore, young 
people such as adolescents and young adults are particularly susceptible to the 
effects of addictive drugs such as nicotine due to their brain not being fully 
developed (Crews et al., 2007; Winters & Arria, 2011). Therefore, they might be at 
major risk of developing nicotine addiction during adulthood and might present 
specific developmental patterns related neuropsychological impairments associated 
to chronic smoking. These should be taken in consideration by future studies. The 
lack of information pertaining alternative methods for nicotine consumption could be 
considered as another limitation for this meta-analysis. In fact, it wasn’t possible to 
identify studies fitting the inclusion and exclusion criteria that were testing the effect 
of alternative methods for nicotine administration on cognition, such as e-cigarettes 
and nicotine replacement therapies (NRT). Finally, the studies included in the 
current review differed consistently in relation to which subcategories of specific 
neuropsychological domains were tested. Older studies were also conducted 
utilizing outdated categories of specific domains. Therefore, in order to conduct the 
meta-analysis we deemed viable to encompass the results from each subcategory 
in eight main domains (see supplementary Table 1) that were sorted by assessing 
the neuropsychological tests utilized by the studies included in the review 
(Baldacchino et al., 2012). This might be considered an important limitation of our 
study.  
 
5.3. Clinical relevance 
There are more than one billion individuals exposed chronically to nicotine. While 
the impact of chronic tobacco smoking on the physical health of individuals is well 
28 
 
   
 
known, and several cessation programs and treatments have been developed to 
reduce morbidity and mortality rates related tobacco smoking, much is to be known 
about its’ impact on the neuropsychology and cognitive functions of individuals. The 
current meta-analysis identified a cross-sectional association between chronic 
tobacco smoking and neuropsychological impairments. Neuropsychological 
impairments related to memory, attention, intelligence, and cognitive flexibility are 
reported to affect negatively the quality of life of individuals as they may undermine 
social relationships, prevent the performance of daily living activities, and may lead 
to neurological diseases such as Alzheimer (Kurz et al.,2003; Lindeboom, & 
Weinstein, 2004; Logsdon et al., 2002; Tarawneh, & Holtzman, 2012). Considering 
the negative impact of neuropsychological impairments on individuals’ life, it 
suggested that pre-treatment neuropsychological assessments and tailored 
Cognitive Rehabilitation Treatments (CRTs) should be implemented in smoking 
cessation programmes. According to Rezapour et al. (2015) “CRT is a general term 
for specialized treatment procedures applied to improve cognitive functions such as 
attention, memory, problem solving, and planning” (p.292). Progress have been 
made in recent years in relation to the development of CRTs for individuals with 
cognitive impairments as a consequence of chronic exposure to opioids and 
alcohol, showing improvements in cognitive functions such as memory, processing 
speed, verbal skills, and problem solving (Ekhtiari, 2014; Rezapour et al., 2017).  
The current meta-analysis also illustrates that individuals exposed chronically to 
nicotine are significantly more impulsive in their decision-making behavior in 
contrast to non-smokers. Therefore, considering a cross-sectional association 
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between chronic smoking and impulsivity (Chase & Hoghart, 2011; Kale et al., 
2018; Kolokotroni et al., 2011) specific treatments such as Cognitive Behavioural 
Therapy (CBT), Dialectical Behavioural Therapy (DBT), and Emotional Regulation 
strategies should be also implemented in smoking cessation programmes in order 
to prevent and reduce negative outcomes consequential to negative impulsive 
choices (Neto, & True, 2011).  
Considering the current meta-analysis identified a cross-sectional association 
between chronic nicotine exposure and neuropsychological impairments, a direct 
causation cannot be inferred. It is well known that substances such as alcohol, 
opioids, and stimulants modulate and/or impair the cognitive abilities of individuals 
and increase impulsivity (e.g. Baldacchino et al., 2012; Mitchell et al., 2005; Reed et 
al., 2012; Verdejo-Garcìa et al., 2007). Taking into account the results of the current 
review, and that alcohol and drugs abusers are more likely to be chronic tobacco 
smokers (Lai et al., 2008; McCool & Richter, 2003; Richter et al., 2002 ), it is 
possible for the neuropsychological impairments identified in these populations to 
have also been confounded by the concomitant chronic nicotine administration. 
However, this notion is further complicated by a pre-morbid confounder such that 
individuals who are affected by neuropsychological impairments are more prone to 
become chronic smokers than individuals without cognitive impairments. To test this 
a longitudinal study would be required. 
 
Furthermore, considering that nicotine may prime the use of other drugs such as 
opioids (and vice versa) through the interaction of opioid and nicotinic-cholinergic 
neurotransmitters systems (Britt & McGehee, 2008; Liu et al., 2013; Yoon et al., 
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2015), and that nicotine administration involves the neurobiological reward 
pathways that also contribute to dependence in other substances (De Biasi & Dani, 
2011; Jasinska et al., 2014; Rose, 2006), drug addiction treatment services should 
also support in smoking cessation programmes. This would not only help to avoid 
relapses, but it would also help to reduce neuropsychological impairments and 
cognitive decline.  
 
6. Conclusion  
The current meta-analysis identified a cross-sectional association between chronic 
tobacco smoking and impairments in seven neuropsychological domains. Future 
studies should focus on investigating the neuropsychological impact of nicotine 
administered chronically through alternative methods such as e-cigarettes and 
NRTs rather than in smoked tobacco. This would enable a further understanding of 
the drug’s impact on the cognitive functions of individuals by ruling out possible 
confounding factors such as chemicals present in tobacco cigarettes. Furthermore, 
considering that in the literature there is a  limited number of reviews exploring the 
link between chronic smoking and neuropsychological impairments of individuals 
across different age ranges, and that the age range of individuals included in the 
current study varied consistently (from 21.5 to 76.8 years), future meta-analyses 
should aim to investigate this association by focusing on specific age groups (e.g. 
adolescents). 
In line with previous research and reviews conducted to assess the 
neuropsychological impact of different types of drugs such as opioids and alcohol, 
the results of the current quantitative synthesis underline the need to develop 
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specific CRTs to improve the cognitive functions of individuals exposed chronically 
to addictive substances. Finally, researchers and practitioners should also consider 
the complex effects of chronic nicotine consumption on cognition when treating 
individuals affected by drug addiction, and when conducting research to investigate 
the neuropsychological effects of other addictive substances. This would improve 
treatment outcomes. 
 
 
 
  
Acknowledgments 
 
We thank NHS Fife Addiction Services and the University of St Andrews 
administrative staff and librarians for their support. 
 
Conflicts of interests 
AB has no conflict of interest with regard to the current work and has received 
educational grants from Schering Plough and has received research project funding 
from Merck Serono, Reckitt Benckiser and Indivior. JDS has no conflict of interest 
with regard to the current work and has received research funding via an 
honorarium associated with a lecture from Wyeth.ST has no conflict of interest with 
regard to the current work and has received funding from Merck Serono and 
Lundbeck. AAC has no conflict of interest. 
 
Funding 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
 
 
 
32 
 
   
 
References 
 
 
Almeida, O. P., Hulse, G. K., Lawrence, D., & Flicker, L., 2002. Smoking as a risk factor for 
Alzheimer’s disease: contrasting evidence from a systematic review of case–control and 
cohort studies. Addiction, 97(1), 15-28. https://doi.org/10.1046/j.1360-0443.2002.00016.x 
Anstey, K. J., von Sanden, C., Salim, A., & O'kearney, R.,2007. Smoking as a risk factor for 
dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol., 
166(4), 367-378. https://doi.org/10.1093/aje/kwm116 
Baldacchino, A., Balfour, D. J. K., Passetti, F., Humphris, G., & Matthews, K., 2012. 
Neuropsychological consequences of chronic opioid use: a quantitative review and meta-
analysis. Neurosci. Biobehav. Rev., 36(9), 2056-
2068.https://doi.org/10.1016/j.neubiorev.2012.06.006 
Benowitz, N. L., 2009. Pharmacology of nicotine: addiction, smoking-induced disease, and 
therapeutics. Annu. Rev. Pharmacol. Toxicol., 49, 57-71. 
https://doi.org/10.1146/annurev.pharmtox.48.113006.094742 
Benowitz, N. L., 2010. Nicotine addiction. N. Engl. J. Med., 362(24), 2295-2303. 
https://dx.doi.org/10.1056%2FNEJMra0809890 
Bloom, E. L., Matsko, S. V., & Cimino, C. R., 2014. The relationship between cigarette smoking and 
impulsivity: A review of personality, behavioral, and neurobiological assessment. Addict. 
Res. Theory, 22(5), 386-397. https://doi.org/10.3109/16066359.2013.867432 
Borenstein, M., Hedges, L., & Rothstein, H., 2007. Meta-analysis: Fixed effect vs. random effects. 
Meta-analysis. com.  
Britt, J. P., & McGehee, D. S., 2008. Presynaptic opioid and nicotinic receptor modulation of 
dopamine overflow in the nucleus accumbens.J. Neurosci., 28(7), 1672-1681. 
https://doi.org/10.1523/JNEUROSCI.4275-07.2008  
Brody, A. L., Mandelkern, M. A., Jarvik, M. E., Lee, G. S., Smith, E. C., Huang, J. C., ... & London, E. 
D., 2004. Differences between smokers and nonsmokers in regional gray matter volumes 
and densities. Biol. Psychiatry , 55(1), 77-84. https://doi.org/10.1016/S0006-3223(03)00610-
3 
Carim-Todd, L., Mitchell, S. H., & Oken, B. S., 2015. Impulsivity and stress response in 
nondependent smokers (tobacco chippers) in comparison to heavy smokers and 
nonsmokers. Nicotine Tob. Res., 18(5), 547-556. https://doi.org/10.1093/ntr/ntv210 
Chamberlain, S. R., Odlaug, B. L., Schreiber, L. R., & Grant, J. E., 2012. Association between 
tobacco smoking and cognitive functioning in young adults. Am. J. Addict., 21, S14-S19. 
https://doi.org/10.1111/j.1521-0391.2012.00290.x 
Chase, H. W., & Hogarth, L., 2011. Impulsivity and symptoms of nicotine dependence in a young 
adult population. Nicotine Tob. Res., 13(12), 1321-1325. https://doi.org/10.1093/ntr/ntr114 
Chen, W. T., Wang, P. N., Wang, S. J., Fuh, J. L., Lin, K. N., & Liu, H. C., 2003. Smoking and 
cognitive performance in the community elderly: a longitudinal study. J. Geriatr. Psychiatry 
Neurol., 16(1), 18-22. http://journals.sagepub.com/doi/abs/10.1177/0891988702250510 
33 
 
   
 
Crews, F., He, J., & Hodge, C.,2007. Adolescent cortical development: a critical period of 
vulnerability for addiction. Pharmacol. Biochem. Behav., 86(2), 189-199. 
https://doi.org/10.1016/j.pbb.2006.12.001 
Cochran, W. G., 1950. The comparison of percentages in matched samples. Biometrika, 37(3/4), 
256-266. DOI: 10.2307/2332378 
Cohen, J.,1994. The earth is round (p < .05). Am. Psychol., 49, 997-1003. 
Cohen, J. (1988). Statistical power analysis for the behavioral sciences 2nd edn. 
Comprehensive Meta Analysis Version 3, 2017. Bio Stat Englewood, New Jersey, US, Accessed 
from: https://www.meta-analysis.com/ 
De Biasi, M., & Dani, J. A., 2011. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci, 34, 
105-130. https://doi.org/10.1146/annurev-neuro-061010-113734 
Deary, I. J., Pattie, A., Taylor, M. D., Whiteman, M. C., Starr, J. M., & Whalley, L. J., 2003. Smoking 
and cognitive change from age 11 to age 80. J. Neurol. Neurosurg. Psychiatry, 74(7), 1006-
1007. http://dx.doi.org/10.1136/jnnp.74.7.1006 
Deeks, J. J., Dinnes, J., D'amico, R., Sowden, A. J., Sakarovitch, C., Song, F., ... & Altman, D. G., 
2003. Evaluating non-randomised intervention studies. Health technology assessment 
(Winchester, England), 7(27), iii-x. 
Dickersin, K., 2005. Publication bias: Recognizing the problem, understanding its origins and scope, 
and preventing harm. Publication bias in meta-analysis: Prevention, assessment and 
adjustments, 11-33.  
Didkowska, J., Wojciechowska, U., Mańczuk, M., & Łobaszewski, J., 2016. Lung cancer 
epidemiology: contemporary and future challenges worldwide. Ann. Transl. Med., 4(8). 
https://dx.doi.org/10.21037%2Fatm.2016.03.11 
Durazzo, T. C., Meyerhoff, D. J., & Nixon, S. J., 2012. A comprehensive assessment of 
neurocognition in middle-aged chronic cigarette smokers. Drug Alcohol Depend., 122(1-2), 
105-111. https://doi.org/10.1016/j.drugalcdep.2011.09.019 
Durazzo, T. C., Meyerhoff, D. J., & Nixon, S. J., 2010. Chronic cigarette smoking: implications for 
neurocognition and brain neurobiology. Int. J. Environ. Res. Public Health,7(10), 3760-3791. 
http://dx.doi.org/10.3390/ijerph7103760 
Durazzo, T. C., Rothlind, J. C., Gazdzinski, S., Banys, P., & Meyerhoff, D. J., 2006. A comparison of 
neurocognitive function in nonsmoking and chronically smoking short-term abstinent 
alcoholics. Alcohol, 39(1), 1-11. https://doi.org/10.1016/j.alcohol.2006.06.006 
Ekhtiari, H., 2014. Alcohol and Cognition; From Neurotoxicity Prevention to Cognitive Rehabilitation. 
Asia Pac. J. Med. Toxicol, 3, 7-7. http://dx.doi.org/10.22038/apjmt.2014.2878 
Elwan, O., Hassan, A. A. H., Naseer, M. A., Elwan, F., Deif, R., El Serafy, O., ... & El Fatatry, 
M.,1997. Brain aging in a sample of normal Egyptians cognition, education, addiction and 
smoking. J, Neurol, Sci, 148(1), 79-86. https://doi.org/10.1016/S0022-510X(96)05336-1 
Ernst, M., Heishman, S. J., Spurgeon, L., & London, E. D., 2001. Smoking history and nicotine 
effects on cognitive performance. Neuropsychopharmacol,, 25(3), 313. 
https://doi.org/10.1016/S0893-133X(01)00257-3 
34 
 
   
 
Friend, K. B., Malloy, P. F., & Sindelar, H. A., 2005. The effects of chronic nicotine and alcohol use 
on neurocognitive function. Addict. Behav., 30(1), 193-202. 
https://doi.org/10.1016/j.addbeh.2004.04.020 
Galanis, D. J., Petrovitch, H., Launer, L. J., Harris, T. B., Foley, D. J., & White, L. R.,1997. Smoking 
history in middle age and subsequent cognitive performance in elderly Japanese-American 
men: the Honolulu-Asia Aging Study. Am. J. Epidemiol., 145(6), 507-
515.https://doi.org/10.1093/oxfordjournals.aje.a009138 
Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P., 2008. 
Tobacco smoking and cancer: A meta‐analysis. Int. J. Cancer, 122(1), 155-164. 
https://doi.org/10.1002/ijc.23033 
HATTA, T., OKUMURA, M., NAGAHARA, N., ITO, E., ITO, Y., & AOKI, K., 2006. Effects of the use 
of cigarettes on the function of frontal lobe in middle and upper middle-aged Japanese 
adults. Psychologia, 49(1), 1-9.https://doi.org/10.2117/psysoc.2006.1 
Hedges, L. V., 1989. A practical guide to modern methods of meta-analysis. National Science 
Teachers Association, 1742 Connecticut Avenue, NW, Washington, DC 20009. 
Hedges, L.V. and Pigott, T.D., 2001. The power of statistical tests in meta-analysis. Psychol. 
Methods, 6(3), p.203. http://psycnet.apa.org/doi/10.1037/1082-989X.6.3.203 
Heishman, S. J., Kleykamp, B. A., & Singleton, E. G., 2010. Meta-analysis of the acute effects of 
nicotine and smoking on human performance. Psychopharmacology, 210(4), 453-469. 
https://doi.org/10.1007/s00213-010-1848-1 
Higgins, J.P. and Thompson, S.G., 2002. Quantifying heterogeneity in a meta‐analysis. Stat. Med., 
21(11), pp.1539-1558. https://doi.org/10.1002/sim.1186 
Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G., 2003. Measuring inconsistency in 
meta-analyses. BMJ: Br. Med. J., 327(7414), 557. 
https://dx.doi.org/10.1136%2Fbmj.327.7414.557 
Hill, R. D.,1989. Residual effects of cigarette smoking on cognitive performance in normal aging. 
Psychology and Aging, 4(2), 251. http://psycnet.apa.org/doi/10.1037/0882-7974.4.2.251 
Hill, R. D., Nilsson, L. G., Nyberg, L., & Bäckman, L., 2003. Cigarette smoking and cognitive 
performance in healthy Swedish adults. Age Ageing, 32(5), 548-
550.https://doi.org/10.1093/ageing/afg067 
Houghton, A. M., Mouded, M., & Shapiro, S. D.,2008. Common origins of lung cancer and COPD. 
Nat. Med., 14(10), 1023. https://doi.org/10.1038/nm1008-1023 
Huxley, R. R., & Woodward, M., 2011. Cigarette smoking as a risk factor for coronary heart disease 
in women compared with men: a systematic review and meta-analysis of prospective cohort 
studies. Lancet, 378(9799), 1297-1305. https://doi.org/10.1016/S0140-6736(11)60781-2 
Ide, R., Mizoue, T., Fujino, Y., Hoshiyama, Y., Sakata, K., Tamakoshi, A., ... & JACC Study Group., 
2008. Cigarette smoking, alcohol drinking, and oral and pharyngeal cancer mortality in 
Japan. Oral Dis., 14(4), 314-319. https://doi.org/10.1111/j.1601-0825.2007.01378.x 
Jasinska, A. J., Zorick, T., Brody, A. L., & Stein, E. A., 2014. Dual role of nicotine in addiction and 
cognition: a review of neuroimaging studies in humans. Neuropharmacology, 84, 111-122. 
https://doi.org/10.1016/j.neuropharm.2013.02.015 
35 
 
   
 
Jayes, L., Haslam, P. L., Gratziou, C. G., Powell, P., Britton, J., Vardavas, C., ... & Fletcher, M. 
(2016). SmokeHaz: systematic reviews and meta-analyses of the effects of smoking on 
respiratory health. Chest, 150(1), 164-179. https://doi.org/10.1016/j.chest.2016.03.060 
Kale, D., Stautz, K., & Cooper, A., 2018. Impulsivity related personality traits and cigarette smoking 
in adults: A meta-analysis using the UPPS-P model of impulsivity and reward sensitivity. 
Drug Alcohol Depend.  https://doi.org/10.1016/j.drugalcdep.2018.01.003 
Kalmijn, S., Van Boxtel, M. P., Verschuren, M. W., Jolles, J., & Launer, L. J., 2002. Cigarette 
smoking and alcohol consumption in relation to cognitive performance in middle age. Am. J. 
Epidemiol., 156(10), 936-944. https://doi.org/10.1093/aje/kwf135 
Kolokotroni, K. Z., Rodgers, R. J., & Harrison, A. A., 2011. Acute nicotine increases both impulsive 
choice and behavioural disinhibition in rats. Psychopharmacology, 217(4), 455-
473.https://link.springer.com/article/10.1007/s00213-011-2296-2 
Kurz, X., Scuvée-Moreau, J., Vernooij-Dassen, M., & Dresse, A., 2003. Cognitive impairment, 
dementia and quality of life. Acta Neurol. Belg., 103, 24-34. 
Lai, S., Lai, H., Page, J. B., & McCoy, C. B., 2000. The association between cigarette smoking and 
drug abuse in the United States. J. Addict. Dis., 19(4), 11-24. 
https://doi.org/10.1300/J069v19n04_02 
Launer, L. J., Feskens, E. J. M., Kalmijn, S., & Kromhout, D., 1996. Smoking, drinking, and thinking: 
The Zutphen Elderly Study: the Zutphen Elderly Study. Am. J. of Epidemiol., 143(3), 219-
227. https://doi.org/10.1093/oxfordjournals.aje.a008732 
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P., ... & Moher, D., 
2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies 
that evaluate health care interventions: explanation and elaboration. PLoS Med., 6(7), 
e1000100. https://doi.org/10.1371/journal.pmed.1000100 
Lindeboom, J., & Weinstein, H., 2004. Neuropsychology of cognitive ageing, minimal cognitive 
impairment, Alzheimer's disease, and vascular cognitive impairment. Eu. J. Pharmacol., 
490(1-3), 83-86. https://doi.org/10.1016/j.ejphar.2004.02.046 
Liu, L., Hendrickson, L. M., Guildford, M. J., Zhao-Shea, R., Gardner, P. D., & Tapper, A. R. ,2013. 
Nicotinic acetylcholine receptors containing the α4 subunit modulate alcohol reward. Biol. 
Psychiatry, 73(8), 738-746. https://doi.org/10.1016/j.biopsych.2012.09.019 
Logsdon, R. G., Gibbons, L. E., McCurry, S. M., & Teri, L., 2002. Assessing quality of life in older 
adults with cognitive impairment. Psychosom. Med., 64(3), 510-519. 
Luhar, R. B., Sawyer, K. S., Gravitz, Z., Ruiz, S. M., & Oscar-Berman, M., 2013. Brain volumes and 
neuropsychological performance are related to current smoking and alcoholism history. 
Neuropsych. Dis. Treat., 9, 1767. https://dx.doi.org/10.2147%2FNDT.S52298 
Lyvers, M., Carlopio, C., Bothma, V., & Edwards, M. S., 2014. Mood, mood regulation, and frontal 
systems functioning in current smokers, long-term abstinent ex-smokers, and never-
smokers. J. Psychoactive Drugs, 46(2), 133-139. 
https://doi.org/10.1080/02791072.2013.876522 
Lyvers, M., Carlopio, C., Bothma, V., & Edwards, M. S., 2013. Mood, mood regulation expectancies 
and frontal systems functioning in current smokers versus never-smokers in China and 
Australia. Addict. Behav., 38(11), 2741-2750. https://doi.org/10.1016/j.addbeh.2013.07.002 
36 
 
   
 
Mani, A., Mullainathan, S., Shafir, E., & Zhao, J., 2013. Poverty impedes cognitive function. Science, 
341(6149), 976-980. DOI: 10.1126/science.1238041 
 Margaritopoulos, G. A., Harari, S., Caminati, A., & Antoniou, K. M., 2016. Smoking‐related idiopathic 
interstitial pneumonia: A review. Respirology, 21(1), 57-64. 
https://doi.org/10.1111/resp.12576 
McCool, R. M., & Richter, K. P. (2003). Why do so many drug users smoke?. J. Subst. Abuse Treat., 
25(1), 43-49.https://doi.org/10.1016/S0740-5472(03)00065-5 
McGrath, M., Wong, J. Y., Michaud, D., Hunter, D. J., & De Vivo, I., 2007. Telomere length, cigarette 
smoking, and bladder cancer risk in men and women. Cancer Epidemiol. Prev. Biomarkers, 
16(4), 815-819. https://doi.org/10.1158/1055-9965.EPI-06-0961 
Mishra, A., Chaturvedi, P., Datta, S., Sinukumar, S., Joshi, P., & Garg, A., 2015. Harmful effects of 
nicotine. Indian J. Med. Paediatr. Oncol., 36(1), 24. https://dx.doi.org/10.4103%2F0971-
5851.151771 
Mitchell, J. M., Fields, H. L., D'esposito, M., & Boettiger, C. A., 2005. Impulsive responding in 
alcoholics. Alcohol. Clin. Exp. Res., 29(12), 2158-2169. 
https://doi.org/10.1097/01.alc.0000191755.63639.4a 
Mitchell, S. H., 2004. Measuring impulsivity and modeling its association with cigarette smoking. 
Behav. Cogn. Neurosci. Rev., 3(4), 261-275. https://doi.org/10.1177%2F1534582305276838 
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., ... & Howard, V. 
J., 2016. Executive summary: heart disease and stroke statistics-2016 update: a report from 
the American Heart Association. Circulation, 133(4), 447-454. DOI: 
10.1161/CIR.0000000000000366 
Murman, D. L. (2015, August). The impact of age on cognition. In Seminars in hearing (Vol. 36, No. 
3, p. 111). Thieme Medical Publishers. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906299/ 
Neto, R. D. C. A., & True, M., 2011. The development and treatment of impulsivity. Psico, 42(1), 134-
141. 
National Heart, Blood and Lung institute, 2018. Study Quality Assessment Tools. retrieved from 
https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools 
Orwin, R. G., 1983. A fail-safe N for effect size in meta-analysis. J. Edu. Stat., 8(2), 157-159. 
https://doi.org/10.3102/10769986008002157 
Ott, A., Andersen, K., Dewey, M. E., Letenneur, L., Brayne, C., Copeland, J. R. M., ... & Stijnen, T., 
2004. Effect of smoking on global cognitive function in nondemented elderly. Neurology, 
62(6), 920-924. https://doi.org/10.1212/01.WNL.0000115110.35610.80 
Paelecke-Habermann, Y., Paelecke, M., Giegerich, K., Reschke, K., & Kübler, A., 2013. Implicit and 
explicit reward learning in chronic nicotine use. Drug Alcohol Depend., 129(1-2), 8-17. 
https://doi.org/10.1016/j.drugalcdep.2012.09.004 
 Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L., & Bulpitt, C., 2008. Smoking, dementia 
and cognitive decline in the elderly, a systematic review. BMC Geriatr., 8(1), 36. 
https://doi.org/10.1186/1471-2318-8-36 
37 
 
   
 
Piumatti, G., Moore, S. C., Berridge, D. M., Sarkar, C., & Gallacher, J., 2018. The relationship 
between alcohol use and long-term cognitive decline in middle and late life: a longitudinal 
analysis using UK Biobank. J. Public Health. DOI : 10.1093/pubmed/fdx186 
Pontieri, F. E., Tanda, G., Orzi, F., & Di Chiara, G.,1996. Effects of nicotine on the nucleus 
accumbens and similarity to those of addictive drugs. Nature, 382(6588), 255. 
https://doi.org/10.1038/382255a0 
Potter, A. S., & Newhouse, P. A., 2008. Acute nicotine improves cognitive deficits in young adults 
with attention-deficit/hyperactivity disorder. Pharmacol. Biochem. Behav., 88(4), 407-
417.https://doi.org/10.1016/j.pbb.2007.09.014 
Razani, J., Boone, K., Lesser, I., & Weiss, D., 2004. Effects of cigarette smoking history on cognitive 
functioning in healthy older adults. Am. J. Geriatr. Psychiatry, 12(4), 404-411. 
https://doi.org/10.1097/00019442-200407000-00008 
Reed, S. C., Levin, F. R., & Evans, S. M., 2012. Alcohol increases impulsivity and abuse liability in 
heavy drinking women. Exp. Clin. Psychopharmacol., 20(6), 454. 
http://psycnet.apa.org/doi/10.1037/a0029087 
Reitz, C., den Heijer, T., van Duijn, C., Hofman, A., & Breteler, M. M. B., 2007. Relation between 
smoking and risk of dementia and Alzheimer disease The Rotterdam Study. Neurology, 
69(10), 998-1005. https://doi.org/10.1212/01.wnl.0000271395.29695.9a 
Rezapour, T., Hatami, J., Farhoudian, A., Sofuoglu, M., Noroozi, A., Daneshmand, R., ... & Ekhtiari, 
H., 2017. Cognitive rehabilitation for individuals with opioid use disorder: A randomized 
controlled trial. Neuropsychol. Rehabil., 1-
17.https://doi.org/10.1080/09602011.2017.1391103 
Rezapour, T., Hatami, J., Farhoudian, A., Sofuoglu, M., Noroozi, A., Daneshmand, R., ... & Ekhtiari, 
H. (2015). NEuro cognitive rehabilitation for disease of addiction (NECOREDA) program: 
from development to trial. Basic Clin. Neurosci., 6(4), 291. 
Richards, M., Jarvis, M. J., Thompson, N., & Wadsworth, M. E., 2003. Cigarette smoking and 
cognitive decline in midlife: evidence from a prospective birth cohort study. Am. J. Public 
Health, 93(6), 994-998. https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.93.6.994 
Richter, K. P., Ahluwalia, H. K., Mosier, M. C., Nazir, N., & Ahluwalia, J. S., 2002. A 
population‐based study of cigarette smoking among illicit drug users in the United States. 
Addiction, 97(7), 861-869. https://doi.org/10.1046/j.1360-0443.2002.00162.x 
Rodgman, A., & Perfetti, T. A., 2016. The chemical components of tobacco and tobacco smoke. 
CRC press. 
Rose, J. E., 2006. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology, 
184(3-4), 274-285. https://link.springer.com/article/10.1007/s00213-005-0250-x 
Rosenthal, R., 1979. The file drawer problem and tolerance for null results. Psychol. Bull., 86(3), 
638. http://psycnet.apa.org/doi/10.1037/0033-2909.86.3.638 
Sabia, S., Elbaz, A., Dugravot, A., Head, J., Shipley, M., Hagger-Johnson, G., ... & Singh-Manoux, 
A., 2012. Impact of smoking on cognitive decline in early old age: the Whitehall II cohort 
study. Arch. Gen. Psychiatry, 69(6), 627-635. doi:10.1001/archgenpsychiatry.2011.2016 
Sachdeva, A., Chandra, M., Choudhary, M., Dayal, P., & Anand, K. S., 2016. Alcohol-related 
dementia and neurocognitive impairment: a review study. Int. J. High. Risk. Behav. Addict., 
5(3). https://dx.doi.org/10.5812%2Fijhrba.27976 
38 
 
   
 
Salthouse, T. A., 2009. When does age-related cognitive decline begin?. Neurobiol. Aging, 30(4), 
507-514. https://doi.org/10.1016/j.neurobiolaging.2008.09.023 
Sasco, A. J., Secretan, M. B., & Straif, K., 2004. Tobacco smoking and cancer: a brief review of 
recent epidemiological evidence. Lung cancer, 45, S3-S9. 
https://doi.org/10.1016/j.lungcan.2004.07.998 
Schinka, J. A., Vanderploeg, R. D., Rogish, M., & Ordorica, P. I., 2002. Effects of alcohol and 
cigarette use on cognition in middle-aged adults. J. Int. Neuropsychol. Soc., 8(5), 683-690. 
https://doi.org/10.1017/S1355617702801412 
Smolka, M. N., Budde, H., Karow, A. C., & Schmidt, L. G., 2004. Neuroendocrinological and 
neuropsychological correlates of dopaminergic function in nicotine dependence. 
Psychopharmacology, 175(3), 374-381. https://link.springer.com/article/10.1007/s00213-
004-1824-8 
Sosa-Ortiz, A. L., Acosta-Castillo, I., & Prince, M. J., 2012. Epidemiology of dementias and 
Alzheimer’s disease. Arch. Med. Res., 43(8), 600-608. 
https://doi.org/10.1016/j.arcmed.2012.11.003 
Stolerman, I. P., & Jarvis, M. J., 1995. The scientific case that nicotine is addictive. 
Psychopharmacology, 117(1), 2-10. https://doi.org/10.1007/BF02245088 
Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., ... & Thacker, S. B., 
2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. 
Jama, 283(15), 2008-2012. doi:10.1001/jama.283.15.2008 
Sweitzer, M. M., Donny, E. C., Dierker, L. C., Flory, J. D., & Manuck, S. B., 2008. Delay discounting 
and smoking: Association with the Fagerström Test for Nicotine Dependence but not 
cigarettes smoked per day. Nicotine Tob. Res., 10(10), 1571-1575. 
https://doi.org/10.1080/14622200802323274 
Talhout, R., Schulz, T., Florek, E., Van Benthem, J., Wester, P., & Opperhuizen, A., 2011. 
Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health, 8(2), 613-628. 
doi:10.3390/ijerph8020613 
Tarawneh, R., & Holtzman, D. M., 2012. The clinical problem of symptomatic Alzheimer disease and 
mild cognitive impairment. Cold Spring Harb. Perspect. Med., a006148. doi: 
10.1101/cshperspect.a006148 
Thompson, S. G., & Higgins, J. P., 2002. How should meta‐regression analyses be undertaken and 
interpreted?. Stat. Med., 21(11), 1559-1573. https://doi.org/10.1002/sim.1187  
Tucker-Drob, E. M.,2011. Neurocognitive functions and everyday functions change together in old 
age. Neuropsychology, 25(3), 368. http://psycnet.apa.org/doi/10.1037/a0022348 
Verdejo-García, A. J., Perales, J. C., & Pérez-García, M., 2007. Cognitive impulsivity in cocaine and 
heroin polysubstance abusers. Addict. Behav., 32(5), 950-966. 
https://doi.org/10.1016/j.addbeh.2006.06.032 
Volkow, N. D., Koob, G. F., & McLellan, A. T., 2016. Neurobiologic advances from the brain disease 
model of addiction. New Engl. J. Med., 374(4), 363-371. DOI: 10.1056/NEJMra1511480  
Waisman Campos, M., Serebrisky, D., & Mauricio Castaldelli-Maia, J.,2016. Smoking and cognition. 
Curr. Drug Abuse Rev., 9(2), 76-79. 
Winters, K. C., & Arria, A., 2011. Adolescent brain development and drugs. Prev. Res., 18(2), 21. 
39 
 
   
 
World Health Organisation, 2018. Tobacco, leading cause of death, illness and impoverishment. 
Retrieved from http://www.who.int/news-room/fact-sheets/detail/tobacco (accessed 12 
March 2018) 
Yakir, A., Rigbi, A., Kanyas, K., Pollak, Y., Kahana, G., Karni, O., ... & Lerer, B., 2007. Why do young 
women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur. 
Neuropsychopharmacol., 17(5), 339-351. https://doi.org/10.1016/j.euroneuro.2006.09.004 
Yoon, J. H., Lane, S. D., & Weaver, M. F., 2015. Opioid analgesics and nicotine: more than blowing 
smoke. J. Pain Palliat. Care. Pharmacother., 29(3), 281-289. 
https://doi.org/10.3109/15360288.2015.1063559 
Yuan, M., Cross, S. J., Loughlin, S. E., & Leslie, F. M., 2015. Nicotine and the adolescent brain. The 
J. Physiol., 593(16), 3397-3412. https://doi.org/10.1113/JP270492 
Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y., 2015. Smoking is associated with an 
increased risk of dementia: a meta-analysis of prospective cohort studies with investigation 
of potential effect modifiers. PloS one, 10(3), e0118333. 
https://doi.org/10.1371/journal.pone.0118333 
 
 
 
 
 
 
 
